Found 271 results
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q., Zhou, Li, Opalinska Joanna, Sohal Davendra, Yu Yiting, Mo Yongkai, Bhagat Tushar, Abdel-Wahab Omar, Fazzari Melissa, Figueroa Maria, Alencar Cristina, et al. , J Biol Chem, 2011 Jul 15, Volume 286, Issue 28, p.25211-23, (2011)
Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity., De, Subhajyoti, Shaknovich Rita, Riester Markus, Elemento Olivier, Geng Huimin, Kormaksson Matthias, Jiang Yanwen, Woolcock Bruce, Johnson Nathalie, Polo Jose M., et al. , PLoS Genet, 2013, Volume 9, Issue 1, p.e1003137, (2013)
Affinity purification probes of potential use to investigate the endogenous Hsp70 interactome in cancer., Rodina, Anna, Taldone Tony, Kang Yanlong, Patel Pallav D., Koren John, Yan Pengrong, Gomes Erica M. DaGama, Yang Chenghua, Patel Maulik R., Shrestha Liza, et al. , ACS Chem Biol, 2014 Aug 15, Volume 9, Issue 8, p.1698-705, (2014)
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90., Moulick, Kamalika, Ahn James H., Zong Hongliang, Rodina Anna, Cerchietti Leandro, DaGama Erica M. Gomes, Caldas-Lopes Eloisi, Beebe Kristin, Perna Fabiana, Hatzi Katerina, et al. , Nat Chem Biol, 2011 Sep 25, Volume 7, Issue 11, p.818-26, (2011)
AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis., Teater, Matt, Dominguez Pilar M., Redmond David, Chen Zhengming, Ennishi Daisuke, Scott David W., Cimmino Luisa, Ghione Paola, Chaudhuri Jayanta, Gascoyne Randy D., et al. , Nat Commun, 2018 Jan 15, Volume 9, Issue 1, p.222, (2018)
AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein., Melnick, A, Carlile G W., McConnell M J., Polinger A, Hiebert S W., and Licht J D. , Blood, 2000 Dec 01, Volume 96, Issue 12, p.3939-47, (2000)
ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression., Abdel-Wahab, Omar, Adli Mazhar, LaFave Lindsay M., Gao Jie, Hricik Todd, Shih Alan H., Pandey Suveg, Patel Jay P., Chung Young Rock, Koche Richard, et al. , Cancer Cell, 2012 Aug 14, Volume 22, Issue 2, p.180-93, (2012)
Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia., Fiskus, Warren, Saba Nakhle, Shen Min, Ghias Mondana, Liu Jinyun, Gupta Soumyasri Das, Chauhan Lata, Rao Rekha, Gunewardena Sumedha, Schorno Kevin, et al. , Cancer Res, 2014 May 01, Volume 74, Issue 9, p.2520-32, (2014)
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities., Flümann, Ruth, Rehkämper Tim, Nieper Pascal, Pfeiffer Pauline, Holzem Alessandra, Klein Sebastian, Bhatia Sanil, Kochanek Moritz, Kisis Ilmars, Pelzer Benedikt W., et al. , Blood Cancer Discov, 2021 Jan, Volume 2, Issue 1, p.70-91, (2021)
Autosomal dominant chorea-acanthocytosis with polyglutamine-containing neuronal inclusions., Walker, R H., Morgello S, Davidoff-Feldman B, Melnick A, Walsh M J., Shashidharan P, and Brin M F. , Neurology, 2002 Apr 09, Volume 58, Issue 7, p.1031-7, (2002)
B
BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint., Swaminathan, Srividya, Huang ChuanXin, Geng Huimin, Chen Zhengshan, Harvey Richard, Kang Huining, Ng Carina, Titz Björn, Hurtz Christian, Sadiyah Mohammed Firas, et al. , Nat Med, 2013 Aug, Volume 19, Issue 8, p.1014-22, (2013)
Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia., Akalin, Altuna, Garrett-Bakelman Francine E., Kormaksson Matthias, Busuttil Jennifer, Zhang Lu, Khrebtukova Irina, Milne Thomas A., Huang Yongsheng, Biswas Debabrata, Hess Jay L., et al. , PLoS Genet, 2012, Volume 8, Issue 6, p.e1002781, (2012)
B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma., Ci, Weimin, Polo Jose M., and Melnick Ari , Curr Opin Hematol, 2008 Jul, Volume 15, Issue 4, p.381-90, (2008)
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells., Valls, Ester, Lobry Camille, Geng Huimin, Wang Ling, Cardenas Mariano, Rivas Martín, Cerchietti Leandro, Oh Philmo, Yang Shao Ning, Oswald Erin, et al. , Cancer Discov, 2017 May, Volume 7, Issue 5, p.506-521, (2017)
BCL6 breaks occur at different AID sequence motifs in Ig-BCL6 and non-Ig-BCL6 rearrangements., Lu, Zhengfei, Tsai Albert G., Akasaka Takashi, Ohno Hitoshi, Jiang Yanwen, Melnick Ari M., Greisman Harvey A., and Lieber Michael R. , Blood, 2013 May 30, Volume 121, Issue 22, p.4551-4, (2013)
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition., Duy, Cihangir, Hurtz Christian, Shojaee Seyedmehdi, Cerchietti Leandro, Geng Huimin, Swaminathan Srividya, Klemm Lars, Kweon Soo-Mi, Nahar Rahul, Braig Melanie, et al. , Nature, 2011 May 19, Volume 473, Issue 7347, p.384-8, (2011)
BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress., Fernando, Tharu M., Marullo Rossella, Gresely Benet Pera, Phillip Jude M., Yang Shao Ning, Lundell-Smith Geoffrey, Torregroza Ingrid, Ahn Haelee, Evans Todd, Gyorffy Balazs, et al. , Cancer Discov, 2019 May, Volume 9, Issue 5, p.662-679, (2019)
BCL6 is critical for the development of a diverse primary B cell repertoire., Duy, Cihangir, J Yu Jessica, Nahar Rahul, Swaminathan Srividya, Kweon Soo-Mi, Polo Jose M., Valls Ester, Klemm Lars, Shojaee Seyedmehdi, Cerchietti Leandro, et al. , J Exp Med, 2010 Jun 07, Volume 207, Issue 6, p.1209-21, (2010)
Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR., Ranuncolo, Stella Maris, Polo Jose M., Dierov Jamil, Singer Michael, Kuo Tracy, Greally John, Green Roland, Carroll Martin, and Melnick Ari , Nat Immunol, 2007 Jul, Volume 8, Issue 7, p.705-14, (2007)
BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection., Zhu, Bibo, Zhang Ruixuan, Li Chaofan, Jiang Li, Xiang Min, Ye Zhenqing, Kita Hirohito, Melnick Ari M., Dent Alexander L., and Sun Jie , Proc Natl Acad Sci U S A, 2019 Jun 11, Volume 116, Issue 24, p.11888-11893, (2019)
BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt., Juszczynski, Przemyslaw, Chen Linfeng, O'Donnell Evan, Polo Jose M., Ranuncolo Stella M., Dalla-Favera Riccardo, Melnick Ari, and Shipp Margaret A. , Blood, 2009 Dec 17, Volume 114, Issue 26, p.5315-21, (2009)
BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms., Hatzi, Katerina, J Nance Philip, Kroenke Mark A., Bothwell Marcella, Haddad Elias K., Melnick Ari, and Crotty Shane , J Exp Med, 2015 Apr 06, Volume 212, Issue 4, p.539-53, (2015)
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms., Parekh, Samir, Polo Jose M., Shaknovich Rita, Juszczynski Przemyslaw, Lev Paola, Ranuncolo Stella M., Yin Yingnan, Klein Ulf, Cattoretti Giorgio, Favera Riccardo Dalla, et al. , Blood, 2007 Sep 15, Volume 110, Issue 6, p.2067-74, (2007)
The BCL6 RD2 domain governs commitment of activated B cells to form germinal centers., Huang, ChuanXin, Gonzalez David G., Cote Christine M., Jiang Yanwen, Hatzi Katerina, Teater Matt, Dai Kezhi, Hla Timothy, Haberman Ann M., and Melnick Ari , Cell Rep, 2014 Sep 11, Volume 8, Issue 5, p.1497-508, (2014)
BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells., Ranuncolo, Stella M., Polo Jose M., and Melnick Ari , Blood Cells Mol Dis, 2008 Jul-Aug, Volume 41, Issue 1, p.95-9, (2008)